NCT06057623View on ClinicalTrials.gov

Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

April 30, 2025

Conditions
Diabetes Mellitus, Type 2Heart Failure Preserved Ejection Fraction
Interventions
OTHER

Evaluation of central and peripheral neuromuscular fatigue

To define peripheral and central component of fatigue, the investigators will test, before, during and after the fatigue task, the force produced during a Maximal Voluntary Contraction (MVC) and the force produced by the electrically evoked Resting Twitch (RT) produced, at rest, 5 seconds after the MVC.

Trial Locations (1)

25065

Istituti Clinici Scientifici Maugeri IRCCS, Lumezzane

All Listed Sponsors
lead

Istituti Clinici Scientifici Maugeri SpA

OTHER

NCT06057623 - Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF | Biotech Hunter | Biotech Hunter